[HTML][HTML] The genetic basis for cancer treatment decisions
Personalized cancer medicine is based on increased knowledge of the cancer mutation
repertoire and availability of agents that target altered genes or pathways. Given advances …
repertoire and availability of agents that target altered genes or pathways. Given advances …
The Genetic Basis for Cancer Treatment Decisions
JE Dancey, PL Bedard, N Onetto, TJ Hudson - Cell, 2012 - infona.pl
Personalized cancer medicine is based on increased knowledge of the cancer mutation
repertoire and availability of agents that target altered genes or pathways. Given advances …
repertoire and availability of agents that target altered genes or pathways. Given advances …
The genetic basis for cancer treatment decisions
JE Dancey, PL Bedard, N Onetto, TJ Hudson - Cell, 2012 - pubmed.ncbi.nlm.nih.gov
Personalized cancer medicine is based on increased knowledge of the cancer mutation
repertoire and availability of agents that target altered genes or pathways. Given advances …
repertoire and availability of agents that target altered genes or pathways. Given advances …
[HTML][HTML] The Genetic Basis for Cancer Treatment Decisions
JE Dancey, PL Bedard, N Onetto, TJ Hudson - Cell, 2012 - cell.com
Personalized cancer medicine is based on increased knowledge of the cancer mutation
repertoire and availability of agents that target altered genes or pathways. Given advances …
repertoire and availability of agents that target altered genes or pathways. Given advances …
[HTML][HTML] The Genetic Basis for Cancer Treatment Decisions
JE Dancey, PL Bedard, N Onetto, TJ Hudson - Cell, 2012 - Elsevier
Personalized cancer medicine is based on increased knowledge of the cancer mutation
repertoire and availability of agents that target altered genes or pathways. Given advances …
repertoire and availability of agents that target altered genes or pathways. Given advances …
[PDF][PDF] The Genetic Basis for Cancer Treatment Decisions
JE Dancey, PL Bedard, N Onetto, TJ Hudson - Cell, 2012 - core.ac.uk
Personalized cancer medicine is based on increased knowledge of the cancer mutation
repertoire and availability of agents that target altered genes or pathways. Given advances …
repertoire and availability of agents that target altered genes or pathways. Given advances …
The Genetic Basis for Cancer Treatment Decisions
JE Dancey, PL Bedard, N Onetto… - Cell Press Reviews …, 2013 - books.google.com
Personalized cancer medicine is based on increased knowledge of the cancer mutation
repertoire and availability of agents that target altered genes or pathways. Given advances …
repertoire and availability of agents that target altered genes or pathways. Given advances …
[引用][C] The Genetic Basis for Cancer Treatment Decisions
JE Dancey, PL Bedard, N Onetto, TJ Hudson - Cell, 2012 - cir.nii.ac.jp
The Genetic Basis for Cancer Treatment Decisions
Ene, 2012 - especialidades.sld.cu
La medicina personalizada en cáncer se basa en un mayor conocimiento del repertorio de
sus mutaciones y la disponibilidad de agentes que atacan las vías o genes alterados. En el …
sus mutaciones y la disponibilidad de agentes que atacan las vías o genes alterados. En el …
The genetic basis for cancer treatment decisions.
JE Dancey, PL Bedard, N Onetto, TJ Hudson - Cell, 2012 - europepmc.org
Personalized cancer medicine is based on increased knowledge of the cancer mutation
repertoire and availability of agents that target altered genes or pathways. Given advances …
repertoire and availability of agents that target altered genes or pathways. Given advances …